Mongan Institute for Health Policy, Massachusetts General Hospital, Harvard Medical School, Department of Medicine, Boston, MA 02114, USA.
J Womens Health (Larchmt). 2011 Jan;20(1):45-52. doi: 10.1089/jwh.2009.1831. Epub 2010 Oct 30.
Among women with chronic, preexisting mobility impairments, we sought to explore how their mobility difficulties affected the diagnosis and treatment of early-stage breast cancer
This is a qualitative analysis of transcripts from in-depth in-person or telephone interviews with 20 English-speaking women who had early-stage breast cancer, were <60 years of age, and had chronic difficulty walking or used wheeled mobility aids at the time of their breast cancer diagnoses
Nine women were disabled by polio as children or had postpolio syndrome, 3 had cerebral palsy, 3 had spinal cord injury, and 5 had other conditions. Most women reported difficulty obtaining mammograms, primarily because of inaccessible equipment, positioning problems, and difficulties with uncontrollable movements. Many women made decisions about surgical approach and chemotherapy by explicitly considering how various therapies would affect their arms, which are essential to their mobility (they use ambulation aids, self-propel manual wheelchairs, or otherwise rely on their arms for mobility or safety). Managing at home after surgery posed major mobility challenges, especially for women who lived alone. Several women reported feeling they suffered more chemotherapy side effects than do women without mobility problems. Weight gains with endocrine therapy compromised the mobility of several women.
Increasing numbers of American women are living with mobility disabilities and entering age ranges with increased risks of breast cancer. Mobility impairments can affect women at every point during early-stage breast cancer diagnosis, therapy, and recovery. Clinicians must consider women's mobility functioning in making therapeutic recommendations to women with impaired mobility who develop breast cancer.
在患有慢性、预先存在的行动障碍的女性中,我们试图探讨她们的行动困难如何影响早期乳腺癌的诊断和治疗。
这是对 20 名讲英语的早期乳腺癌女性的深入个人或电话访谈记录的定性分析,这些女性年龄<60 岁,在乳腺癌诊断时患有慢性行走困难或使用轮式移动辅助器具。
9 名女性因小儿麻痹症而残疾或患有脊髓灰质炎后综合征,3 名女性患有脑瘫,3 名女性患有脊髓损伤,5 名女性患有其他疾病。大多数女性报告难以获得乳房 X 光检查,主要是因为设备无法使用、定位问题和不可控运动的困难。许多女性通过明确考虑各种疗法如何影响她们的手臂来决定手术方法和化疗方案,因为手臂对她们的移动性至关重要(她们使用步行辅助器具、自行推动手动轮椅或以其他方式依靠手臂来移动或保持安全)。手术后在家中管理也带来了重大的移动性挑战,尤其是对于独居的女性。一些女性报告说,她们比没有移动问题的女性遭受更多的化疗副作用。内分泌治疗引起的体重增加使几位女性的移动能力受到影响。
越来越多的美国女性患有行动障碍,并进入乳腺癌风险增加的年龄段。行动障碍可能会影响早期乳腺癌诊断、治疗和康复过程中的每个女性。临床医生在为患有行动障碍的乳腺癌女性提供治疗建议时,必须考虑到女性的移动功能。